Advertisement
UK markets open in 28 minutes

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,738.71
    +454.17 (+2.63%)
     

  • CRUDE OIL

    84.00
    +0.43 (+0.51%)
     

  • GOLD FUTURES

    2,351.40
    +8.90 (+0.38%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • Bitcoin GBP

    51,521.01
    +116.92 (+0.23%)
     

  • CMC Crypto 200

    1,391.68
    -4.85 (-0.35%)
     

  • NASDAQ Composite

    15,611.76
    -100.99 (-0.64%)
     

  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     
Stocks:

Trending tickers

Microsoft, Alphabet, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's

BUZZ-AstraZeneca PLC: Cancer pipeline boost

Reuters - UK Focus

** British drugmaker's U.S-listed shares up 2 pct at $75.85 after cancer drug pipeline boost

** Company's immuno-oncology medicine for colorectal cancer to be tested in mid-stage study

** Move (NasdaqGS: MOVE - news) opens up "a potentially multi-blockbuster opportunity", say analysts at UBS (NYSEArca: FBGX - news) , which rates the stock "buy"

** Shares (Frankfurt: DI6.F - news) also remain propped up by speculation of a possible renewed bid from Pfizer (NYSE: PFE - news)

** Up to Thursday's close, the stock had fallen 7.5 pct since May 16, the last trading day before AstraZeneca (NYSE: AZN - news) rejected Pfizer's sweetened and "final" offer (Reuters Messaging:; natalie.grover.thomsonreuters.com@reuters.net)